Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
書誌事項
- 公開日
- 2018-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- http://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.1016/s0140-6736(18)32486-3
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- The Lancet
-
The Lancet 392 (10162), 2353-2366, 2018-12
Elsevier BV
